Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

More articles from Article

  • You have access
    Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
    Kaushik Datta, Paul M. Sherblom and Arun P. Kulkarni
    Drug Metabolism and Disposition February 1997, 25 (2) 196-105;
  • You have access
    Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C- and 3H-Labeled Ziprasidone
    Chandra Prakash, Amin Kamel, Wayne Anderson and Harry Howard
    Drug Metabolism and Disposition February 1997, 25 (2) 206-218;
  • You have access
    Diazepam Metabolism by cDNA-Expressed Human 2C P450s
    Frank Jung, Toby H. Richardson, Judy L. Raucy and Eric F. Johnson
    Drug Metabolism and Disposition February 1997, 25 (2) 133-139;
  • You have access
    A Comparative Investigation of 2-Propyl-4-Pentenoic Acid (4-ene VPA) and its α-Fluorinated Analogue: Phase II Metabolism and Pharmacokinetics
    Wei Tang and Frank S. Abbott
    Drug Metabolism and Disposition February 1997, 25 (2) 219-227;
  • You have access
    Disposition and Metabolism of Tenidap in the Rat
    Hassan G. Fouda, Michael J. Avery, Deepak Dalvie, Fred C. Falkner, Lawrence S. Melvin and Robert A. Ronfeld
    Drug Metabolism and Disposition February 1997, 25 (2) 140-148;
  • You have access
    Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats
    Mayland Chang, Virendra K. Sood, Gracella J. Wilson, David A. Kloosterman, Phillip E. Sanders, Michael J. Hauer and Paul E. Fagerness
    Drug Metabolism and Disposition February 1997, 25 (2) 228-242;
  • You have access
    Comparison of in Vitro Carnitine and Glycine Conjugation with Branched-Side Chain and Cyclic Side Chain Carboxylic Acids in Rats
    Takushi Kanazu and Toshiro Yamaguchi
    Drug Metabolism and Disposition February 1997, 25 (2) 149-153;
  • You have access
    Metabolic Inactivation of Cytochrome P4502B1 by Phencyclidine
    Uma Sharma, Elizabeth S. Roberts, Ute M. Kent, S. Michael Owens and Paul F. Hollenberg
    Drug Metabolism and Disposition February 1997, 25 (2) 243-250;
  • You have access
    Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN′-Nitrosonornicotine in Human Hepatic Microsomes
    Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich and Stephen S. Hecht
    Drug Metabolism and Disposition February 1997, 25 (2) 154-162;
  • You have access
    Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds
    Christopher D. King, Gladys R. Rios, Mitchell D. Green, Peter I. Mackenzie and Thomas R. Tephly
    Drug Metabolism and Disposition February 1997, 25 (2) 251-255;

Pages

  • Previous
  • Next
  • 1
  • …
  • 501
  • 502
  • 503
  • 504
  • 505
  • 506
  • 507
  • 508
  • 509
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics